Cyclist beats red light and gets hit by car; car is okay

Apr 01, 2021 | 🚀 Fathership

A 39-year-old cyclist was taken to hospital after he was hit by a car at the junction of Orchard Road and Scotts Road on Mar 6.

A reader alerted Fathership to the incident and shared that his father was the driver of the car involved.

"This incident was encountered by my father who is a Grab driver," he said.

"He was driving along Orchard Road on 6th March 2021 around 7:43am.

"Given that it was green light in favour of the driver, it would have been almost impossible for the cyclist’s claim of 'having the right of way as his direction is in green light' to be true.

"This is also clearly shown in the video as well.

"Cyclist now insists that my father is [at] fault."

The reader added that although his father did not suffer any injuries from the accident, he was in shock for a few days and "did not dare to drive".

"I hope you can help to share this story," he said.

"My poor dad earning his hard-earned money."

In response to Fathership's query, the police said they were alerted to the accident at 7.47am.

Police investigations are ongoing.

S'pore firm develops first Omicron-specific testing kit

Dec 06, 2021 | 🚀 Fathership
Home-grown biotechnology firm BioAcumen Global has launched Singapore's first Omicron-specific Covid-19 polymerase chain reaction (PCR) kit.

This means that a person taking the test will receive one of three results: Covid-19 positive and Omicron positive; Covid-19 positive and Omicron negative; or Covid-19 and Omicron negative.

Currently, PCR kits here that are capable of detecting Omicron require an additional gene sequencing step to confirm the specific variant. This takes an additional day.

Some PCR kits, such as those currently in use by medical technology firm Acumen Diagnostics and biotech firm MiRXES, are able to detect both the Delta and the Omicron strains, but to confirm if a positive case has been infected by Omicron, gene sequencing is necessary.

Mr Jimmy Toh, director of BioAcumen Global, said: "We are looking at ways to cut down the steps and time needed to run this test. This is crucial, especially at the borders where accurate tests need to be done on-site. There is no time to wait on sequencing results to know if a positive sample is infected with Omicron."

Mass production of the kit has begun, and the BioAcumen Global team hopes this kit will provide much needed help locally and in the region for the surveillance and control of this new variant, Mr Toh said.